A detailed history of D. E. Shaw & Co., Inc. transactions in Medtronic PLC stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 353,774 shares of MDT stock, worth $28.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
353,774
Holding current value
$28.8 Million
% of portfolio
0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$76.84 - $91.03 $12.6 Million - $14.9 Million
163,449 Added 85.88%
353,774 $31.9 Million
Q2 2024

Aug 14, 2024

SELL
$78.71 - $87.02 $15.2 Million - $16.8 Million
-193,551 Reduced 50.42%
190,325 $15 Million
Q1 2024

May 15, 2024

BUY
$82.84 - $88.09 $14.2 Million - $15.1 Million
170,862 Added 80.21%
383,876 $33.5 Million
Q4 2023

Feb 14, 2024

BUY
$69.43 - $83.43 $7.99 Million - $9.61 Million
115,146 Added 117.65%
213,014 $17.5 Million
Q3 2023

Nov 14, 2023

BUY
$78.22 - $90.4 $538,310 - $622,132
6,882 Added 7.56%
97,868 $7.67 Million
Q2 2023

Aug 14, 2023

SELL
$79.47 - $91.38 $54.9 Million - $63.1 Million
-690,434 Reduced 88.36%
90,986 $8.02 Million
Q1 2023

May 15, 2023

SELL
$76.72 - $87.58 $186 Million - $212 Million
-2,425,515 Reduced 75.63%
781,420 $63 Million
Q4 2022

Feb 14, 2023

BUY
$76.18 - $87.74 $108 Million - $125 Million
1,424,203 Added 79.89%
3,206,935 $249 Million
Q3 2022

Nov 14, 2022

SELL
$80.75 - $95.31 $7.94 Million - $9.37 Million
-98,317 Reduced 5.23%
1,782,732 $144 Million
Q2 2022

Aug 15, 2022

SELL
$87.4 - $113.09 $4.97 Million - $6.43 Million
-56,875 Reduced 2.93%
1,881,049 $169 Million
Q1 2022

May 16, 2022

SELL
$100.58 - $112.38 $184 Million - $205 Million
-1,824,514 Reduced 48.49%
1,937,924 $215 Million
Q4 2021

Feb 14, 2022

BUY
$99.53 - $127.75 $250 Million - $321 Million
2,509,590 Added 200.31%
3,762,438 $389 Million
Q3 2021

Nov 15, 2021

SELL
$122.75 - $135.17 $236 Million - $259 Million
-1,919,550 Reduced 60.51%
1,252,848 $157 Million
Q2 2021

Aug 16, 2021

SELL
$118.19 - $131.5 $71.9 Million - $80 Million
-608,574 Reduced 16.1%
3,172,398 $394 Million
Q1 2021

May 17, 2021

BUY
$111.18 - $119.74 $148 Million - $159 Million
1,327,273 Added 54.09%
3,780,972 $447 Million
Q4 2020

Feb 16, 2021

SELL
$100.57 - $117.14 $5.83 Million - $6.79 Million
-57,936 Reduced 2.31%
2,453,699 $287 Million
Q3 2020

Nov 16, 2020

SELL
$90.13 - $108.78 $52.7 Million - $63.6 Million
-584,451 Reduced 18.88%
2,511,635 $261 Million
Q2 2020

Aug 14, 2020

BUY
$84.11 - $103.33 $108 Million - $133 Million
1,287,775 Added 71.21%
3,096,086 $284 Million
Q1 2020

May 15, 2020

BUY
$72.92 - $121.3 $36.7 Million - $61.1 Million
503,746 Added 38.61%
1,808,311 $163 Million
Q4 2019

Feb 14, 2020

SELL
$104.49 - $114.54 $61.7 Million - $67.6 Million
-590,042 Reduced 31.14%
1,304,565 $148 Million
Q3 2019

Nov 14, 2019

SELL
$98.02 - $111.18 $337 Million - $382 Million
-3,438,934 Reduced 64.48%
1,894,607 $206 Million
Q2 2019

Aug 14, 2019

BUY
$84.15 - $99.38 $78 Million - $92.2 Million
927,269 Added 21.04%
5,333,541 $519 Million
Q1 2019

May 15, 2019

BUY
$82.45 - $93.79 $186 Million - $212 Million
2,255,449 Added 104.86%
4,406,272 $401 Million
Q4 2018

Feb 14, 2019

BUY
$85.8 - $99.49 $131 Million - $152 Million
1,523,109 Added 242.64%
2,150,823 $196 Million
Q3 2018

Nov 14, 2018

SELL
$85.91 - $99.17 $62.7 Million - $72.4 Million
-730,271 Reduced 53.78%
627,714 $61.7 Million
Q2 2018

Aug 14, 2018

SELL
$77.48 - $87.83 $157 Million - $178 Million
-2,030,836 Reduced 59.93%
1,357,985 $116 Million
Q1 2018

May 15, 2018

SELL
$76.55 - $87.26 $71.9 Million - $82 Million
-939,803 Reduced 21.71%
3,388,821 $272 Million
Q4 2017

Feb 14, 2018

BUY
$76.93 - $83.5 $216 Million - $234 Million
2,802,318 Added 183.6%
4,328,624 $350 Million
Q3 2017

Nov 14, 2017

BUY
$77.71 - $84.6 $119 Million - $129 Million
1,526,306
1,526,306 $119 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.